AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Stroke prophylaxis in nonvalvular atrial fibrillation
Authors: Bungard, TJ Shuaib, A Tsuyuki, RT
Citation: Tj. Bungard et al., Stroke prophylaxis in nonvalvular atrial fibrillation, CURR OP NEU, 14(1), 2001, pp. 59-65
Physicians' perceptions of the benefits and risks of warfarin for patientswith nonvalvular atrial fibrillation
Authors: Bungard, TJ Ghali, WA McAlister, FA Buchan, AM Cave, AJ Hamilton, PG Mitchell, LB Shuaib, A Teo, KK Tsuyuki, RT
Citation: Tj. Bungard et al., Physicians' perceptions of the benefits and risks of warfarin for patientswith nonvalvular atrial fibrillation, CAN MED A J, 165(3), 2001, pp. 301-302
Cholesterol risk management: A systematic examination of the gap from evidence to practice
Authors: Olson, KL Bungard, TJ Tsuyuki, RT
Citation: Kl. Olson et al., Cholesterol risk management: A systematic examination of the gap from evidence to practice, PHARMACOTHE, 21(7), 2001, pp. 807-817
Practice-based research: Lessons from community pharmacist participants
Authors: Simpson, SH Johnson, JA Biggs, C Biggs, RS Kuntz, A Semchuk, W Taylor, JG Farris, KB Tsuyuki, RT
Citation: Sh. Simpson et al., Practice-based research: Lessons from community pharmacist participants, PHARMACOTHE, 21(6), 2001, pp. 731-739
Poor adherence with hypolipidemic drugs: A lost opportunity
Authors: Tsuyuki, RT Bungard, TJ
Citation: Rt. Tsuyuki et Tj. Bungard, Poor adherence with hypolipidemic drugs: A lost opportunity, PHARMACOTHE, 21(5), 2001, pp. 576-582
Economic impact of community pharmacist intervention in cholesterol risk management: An evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists
Authors: Simpson, SH Johnson, JA Tsuyuki, RT
Citation: Sh. Simpson et al., Economic impact of community pharmacist intervention in cholesterol risk management: An evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists, PHARMACOTHE, 21(5), 2001, pp. 627-635
Do hypolipidemic drugs lower medical expenses? Authors' reply
Authors: Tsuyuki, RT Bungard, T
Citation: Rt. Tsuyuki et T. Bungard, Do hypolipidemic drugs lower medical expenses? Authors' reply, PHARMACOTHE, 21(12), 2001, pp. 1584-1586
Underutilisation of ACE inhibitors in patients with congestive heart failure
Authors: Bungard, TJ McAlister, FA Johnson, JA Tsuyuki, RT
Citation: Tj. Bungard et al., Underutilisation of ACE inhibitors in patients with congestive heart failure, DRUGS, 61(14), 2001, pp. 2021-2033
Controlling the ischemic heart disease epidemic: Strategies for the 21st century
Authors: Majumdar, SR Tsuyuki, RT McAlister, FA
Citation: Sr. Majumdar et al., Controlling the ischemic heart disease epidemic: Strategies for the 21st century, CAN J PUBL, 92(1), 2001, pp. 9
Acute precipitants of congestive heart failure exacerbations
Authors: Tsuyuki, RT McKelvie, RS Arnold, JMO Avezum, A Barretto, ACP Carvalho, ACC Isaac, DL Kitching, AD Piegas, LS Teo, KK Yusuf, S
Citation: Rt. Tsuyuki et al., Acute precipitants of congestive heart failure exacerbations, ARCH IN MED, 161(19), 2001, pp. 2337-2342
Use of statins and the subsequent development of deep vein thrombosis
Authors: Ray, JG Mamdani, M Tsuyuki, RT Anderson, DR Yeo, EL Laupacis, A
Citation: Jg. Ray et al., Use of statins and the subsequent development of deep vein thrombosis, ARCH IN MED, 161(11), 2001, pp. 1405-1410
The development of an internet-based course on dyslipidemias: A new form of continuing education for pharmacists
Authors: Olson, KL Schindel, T Geissler, C Tsuyuki, RT
Citation: Kl. Olson et al., The development of an internet-based course on dyslipidemias: A new form of continuing education for pharmacists, AM J PHAR E, 65(1), 2001, pp. 13-19
beta-blockers for congestive heart failure - What is the current consensus?
Authors: Tsuyuki, RT McAlister, FA Teo, KK
Citation: Rt. Tsuyuki et al., beta-blockers for congestive heart failure - What is the current consensus?, DRUG AGING, 16(1), 2000, pp. 1-7
Levels of evidence in cardiovascular clinical practice guidelines
Authors: Ackman, ML Druteika, D Tsuyuki, RT
Citation: Ml. Ackman et al., Levels of evidence in cardiovascular clinical practice guidelines, CAN J CARD, 16(10), 2000, pp. 1249-1254
RE: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation.1998;14 : 695-702.
Authors: Tsuyuki, RT Walters, B Yim, R Teo, KK
Citation: Rt. Tsuyuki et al., RE: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation.1998;14 : 695-702., CAN J CARD, 16(1), 2000, pp. 99-99
Adequacy of anticoagulation in patients with atrial fibrillation coming toa hospital
Authors: Bungard, TJ Ackman, ML Ho, G Tsuyuki, RT
Citation: Tj. Bungard et al., Adequacy of anticoagulation in patients with atrial fibrillation coming toa hospital, PHARMACOTHE, 20(9), 2000, pp. 1060-1065
Using focus groups to identify barriers to drug use in patients with congestive heart failure
Authors: Simpson, SH Farris, KB Johnson, JA Tsuyuki, RT
Citation: Sh. Simpson et al., Using focus groups to identify barriers to drug use in patients with congestive heart failure, PHARMACOTHE, 20(7), 2000, pp. 823-829
Underuse of inhaled corticosteroids in adults with asthma
Authors: Yuksel, N Ginther, S Man, P Tsuyuki, RT
Citation: N. Yuksel et al., Underuse of inhaled corticosteroids in adults with asthma, PHARMACOTHE, 20(4), 2000, pp. 387-393
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study
Authors: Cirillo, W Decanini, R Coelho, OR Avezum, A Peixoto, MSP Piegas, LS Neto, JMR Paiva, M Carvalho, AC de Almeida, DR Fernandes, IML Malavasi, MC Pavanello, R Canesin, M Ishii, S Barretto, ACP Imrie, J Moore, R Woo, K Bernstein, V Mizgala, HF Mooney, S Hilbich, D Kuritzky, R Rupka, DW Blackwell, MM Breakwell, L Kornder, JM Pearce, SA Polasek, P Richardson, PM Grant, J Isaac, D Beresford, P Giannoccaro, P Roth, D Greenwood, P Muzyka, T Prosser, A Brass, N Hui, W Kvill, L Goeres, M MacDonald, K Senaratne, M Hill, L Humen, D Teo, KK Habib, N Habib, N Teekasingh, S MacKenzie, J McEwen, B Morris, A Dhair, A Lai, C Kwiatkowski, K Brugos, J Nawaz, S Andrews, J Moe, G Freskiw, K Gilbert, B Morgan, CD Bozek, B Halperin, F Ricci, AJ Singh, N Cappelli, G Boyne, T Fallen, E Panju, A Woodcock, G Kent, E Kitching, AD Sullivan, H Tomson, D McKelvie, RS Tsuyuki, RT Yusuf, S Chan, YK Thomson, D Arnold, JMO Hurwitz, G Miles, R Baker, A Haspect, A Smith, S Bedard, J Lavoie, L Dufort, L Harvey, R Lepage, S Elstein, E Fitchett, D Serpa, A Day, L Racine, N Savard, D Sestier, F Gosselin, G Rouleau, JL White, M Whittom, L Kiwan, G Kouz, SM Laforest, M Ouimet, H Carmichael, P Lenis, J Auger, P Grondin, F Saulnier, D Campeau, J Dupuis, R Lauzon, C Genest, M Robitaille, NM Beaudoin, J Belanger, N Houde, G Talbot, P Cossett, J Koilpillai, C Sheridan, WJ Tobin, M Sussex, B Ascoli, G Fraticelli, A Paciaroni, E Como, CO Belluschi, R Ruffa, F Tettamanti, F Cobelli, F Salvucci, F Arpesella, R Campana, C Gavazzi, A Cirrincione, V Ingrilli, F Sciortino, E Boccanelli, A Cacciatore, G Menichelli, M Bosimini, E Giannuzzi, P Marcassa, C Porcu, M Salis, S Sanna, A Comerio, G Gronda, E Mangiavacchi, M Moccetti, T Pasotti, E Sessa, F Levy, WC Probstfield, J Thompson, J Gramberg, M Grover, J Towery, D Ogunyankin, K Singh, BN Celano, J Graham, S Kohn, RM Pande, P Sass, A Wiener, RS Rydzinski, S Starling, RC Young, J Hays, L Naftilan, A Miller, A Varga, A Wofford, R Barnhill, S Brito, RD Harris, L Haspect, A Cristina, T Jarosz, M Kellen, J Kingry, C Letterer, R La Forge, D Liuni, C MacKenzie, J Magi, A Stevens, K Squires, P Yusuf, S Rouleau, JL Maggioni, A Arnold, JMO Avezum, A Burns, R Floras, J Gavazzi, A Held, P Hjalmarson, A Isaac, D Latini, R Lindgren, E McKelvie, RS Piegas, LS Pericak, D Pogue, J Probstfield, J Smith, S Swedberg, K Teo, KK Tsuyuki, RT Vint-Reed, C Wang, Y White, M Wiecek, EM Young, J Johnstone, D Armstrong, PW Packer, M Wedel, H Teo, KK Gavazzi, A Tsuyuki, RT White, M McKelvie, R Anderson, M Holadyk-Gris, I Kucemba, K MacKay, J McKelvie, RS Micks, M Pericak, D Pogue, J Reeve, S Robinson, L Tsuyuki, RT Tucker, J Wiecek, EM Wang, Y Yusuf, S Cernacek, P Joyal, M Poitras, N Rouleau, JL White, M Sirois, P Bevilacqua, M Latini, R Masson, S Torri, M Hall, C Burns, RJ Heeney, T Tadros, S White, M Yusuf, S McKelvie, RS Pericak, D Young, J Latini, R Pogue, J Burns, RJ Probstfield, J Tsuyuki, RT Maggioni, AP Avezum, A Rouleau, JL
Citation: W. Cirillo et al., Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy - The randomized evaluation of strategies for left ventricular dysfunction pilot study, CIRCULATION, 101(4), 2000, pp. 378-384
Warfarin therapy for atrial fibrillation: The patient's preference is important - In Reply
Authors: Tsuyuki, RT McAlister, FA Bungard, TJ Ghali, WA Teo, KK
Citation: Rt. Tsuyuki et al., Warfarin therapy for atrial fibrillation: The patient's preference is important - In Reply, ARCH IN MED, 160(15), 2000, pp. 2403-2403
Why do patients with atrial fibrillation not receive warfarin?
Authors: Bungard, TJ Ghali, WA Teo, KK McAlister, FA Tsuyuki, RT
Citation: Tj. Bungard et al., Why do patients with atrial fibrillation not receive warfarin?, ARCH IN MED, 160(1), 2000, pp. 41-46
Study of cardiovascular risk intervention by pharmacists (SCRIP): A randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk
Authors: Tsuyuki, RT Johnson, JA Teo, KK Ackman, ML Biggs, RS Cave, A Chang, WC Dzavik, V Farris, KB Galvin, D Semchuk, W Simpson, SH Taylor, JG
Citation: Rt. Tsuyuki et al., Study of cardiovascular risk intervention by pharmacists (SCRIP): A randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk, ANN PHARMAC, 33(9), 1999, pp. 910-919
Use of nonprescription medications by patients with congestive heart failure
Authors: Ackman, ML Campbell, JB Buzak, KA Tsuyuki, RT Montague, TJ Teo, KK
Citation: Ml. Ackman et al., Use of nonprescription medications by patients with congestive heart failure, ANN PHARMAC, 33(6), 1999, pp. 674-679
Contemporary utilization of digoxin in patients with atrial fibrillation
Authors: McAlister, FA Ackman, ML Tsuyuki, RT Kimber, S Teo, KK
Citation: Fa. Mcalister et al., Contemporary utilization of digoxin in patients with atrial fibrillation, ANN PHARMAC, 33(3), 1999, pp. 289-293
Comparison of candesartan, enalapril, and their combination in congestive heart failure - Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study - The RESOLVD pilot study investigators
Authors: McKelvie, RS Yusuf, S Pericak, D Avezum, A Burns, RJ Probstfield, J Tsuyuki, RT White, M Rouleau, J Latini, R Maggioni, A Young, J Pogue, J
Citation: Rs. Mckelvie et al., Comparison of candesartan, enalapril, and their combination in congestive heart failure - Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study - The RESOLVD pilot study investigators, CIRCULATION, 100(10), 1999, pp. 1056-1064
Risultati: 1-25 | 26-27